The global interventional cardiology devices market is undergoing significant transformation as cardiovascular diseases continue to place pressure on healthcare systems and physicians increasingly adopt minimally invasive approaches to cardiac treatment. Rising cases of coronary artery disease, an aging population, obesity, hypertension, diabetes, and lifestyle-related risk factors are creating sustained demand for advanced cardiovascular intervention technologies. At the same time, improvements in medical-device design are enabling healthcare professionals to treat increasingly complex cardiac conditions with greater precision and efficiency.

The global interventional cardiology devices market was valued at USD 11.3 billion in 2025 and is projected to reach USD 19.8 billion by 2033, expanding from USD 12.1 billion in 2026 at a CAGR of 7.3% from 2026 to 2033. The continued expansion reflects growing cardiovascular disease prevalence, increasing adoption of minimally invasive procedures, and ongoing technological development across coronary intervention devices.

Download a free sample copy of the Interventional Cardiology Devices Market report to understand detailed coverage and inclusions in the final report

Market Breakdown by Segment

By Product

• Coronary Stents (Largest Share): Coronary stents accounted for 48.3% of revenue in 2025, making them the leading product segment. Their widespread use in percutaneous coronary intervention (PCI), combined with continuing improvements in drug-eluting stents and delivery systems, is supporting segment growth. Manufacturers are focusing on thinner strut designs, improved deliverability, and advanced drug-eluting technologies to improve procedural performance.

• PTCA Balloon Catheters: Percutaneous transluminal coronary angioplasty balloon catheters remain an essential part of coronary interventions. Normal, specialty, and drug-coated balloons are used to prepare and treat narrowed coronary arteries. Product innovation is increasingly focused on improving lesion crossing, vessel preparation, and drug delivery.

• Intravascular Imaging Catheters and Pressure Guidewires: These technologies are becoming increasingly important as physicians seek greater visibility and physiological information during procedures. IVUS and OCT technologies allow clinicians to evaluate vessel characteristics and optimize stent placement, while pressure guidewires support physiology-guided treatment decisions.

• Accessory Devices: The accessory devices segment is expected to record the fastest CAGR during the forecast period. Advanced guidewires, guiding catheters, introducer sheaths, and micro-guide catheters are increasingly important for complex PCI procedures where navigation through tortuous or heavily diseased vessels is challenging.

By Procedure

• Coronary Artery Disease (Largest Share): The coronary artery disease segment held 52.2% of revenue in 2025. The segment continues to benefit from the need to restore coronary blood flow and reduce the risk of serious cardiovascular events. Improvements in PCI, stent technologies, intravascular imaging, and lesion-preparation devices are helping physicians manage increasingly complex cases.

• Chronic Total Occlusion: CTO procedures are becoming an important area of technological development. These interventions require specialized operator expertise and advanced crossing techniques because completely blocked coronary arteries can be difficult to navigate. Increasing adoption of sophisticated guidewires, imaging technologies, and crossing systems is creating new opportunities within this segment.

• Acute Myocardial Infarction: Interventional cardiology also plays a critical role in emergency treatment of acute myocardial infarction. Rapid restoration of blood flow through PCI can be essential in managing patients with acute coronary events, supporting continued demand for reliable intervention devices.

By End Use

• Hospitals (Largest Share): Hospitals accounted for 70.8% of revenue in 2025, reflecting their central role in treating complex cardiovascular conditions. Hospitals provide catheterization laboratories, emergency services, advanced imaging, surgical backup, and post-procedure monitoring, making them the primary setting for many interventional cardiology procedures.

• Ambulatory Surgical Centers: ASCs are gaining attention as healthcare providers look for cost-efficient approaches to suitable minimally invasive procedures. Their ability to support shorter stays and streamlined patient pathways could encourage further adoption of selected interventional cardiology procedures outside traditional hospital settings.

Core Market Drivers & Technology Trends

Growing Cardiovascular Disease Burden: The increasing prevalence of cardiovascular diseases is one of the strongest demand drivers. Conditions associated with obesity, hypertension, diabetes, aging, sedentary lifestyles, and unhealthy diets are creating a larger population requiring diagnosis and intervention. 

Shift Toward Minimally Invasive Treatment: Catheter-based procedures are increasingly preferred because they can reduce blood loss, shorten recovery periods, and avoid some of the risks associated with open-heart procedures. Growing adoption of PCI and other minimally invasive cardiovascular interventions is therefore supporting demand for stents, catheters, guidewires, and imaging technologies.

Advanced Intravascular Imaging: IVUS and OCT are becoming increasingly valuable for complex coronary procedures. Real-time visualization helps physicians evaluate lesions, understand vessel characteristics, and optimize device positioning. In October 2025, Terumo Interventional Systems received FDA 510(k) clearance for its OPUSWAVE Dual Sensor Imaging System and DualView imaging catheter, which combines OFDI and IVUS in a single catheter.

Innovation in Complex PCI: Manufacturers are developing technologies designed to address difficult lesions and heavily calcified vessels. Intravascular lithotripsy, advanced guidewires, micro-guide catheters, and specialized balloon technologies are expanding the tools available to physicians performing complex interventions.

Increasing PCI Procedures: Rising demand for PCI is directly supporting device consumption. The procedure remains a common approach for treating coronary artery disease by restoring blood flow through narrowed or obstructed arteries.

Regional Outlook

North America: North America dominated the global industry with a 46.1% revenue share in 2025. Strong healthcare infrastructure, high cardiovascular disease prevalence, advanced catheterization facilities, and rapid adoption of minimally invasive technologies are supporting regional demand. The U.S. accounted for the largest share within North America.

Europe: Europe represents an established market supported by sophisticated healthcare systems and growing adoption of drug-eluting stents, PTCA balloon catheters, intravascular imaging, and other advanced cardiovascular technologies. Hospitals are increasingly incorporating precision imaging and minimally invasive treatment approaches into cardiac care.

Asia Pacific: Asia Pacific offers significant future opportunities as healthcare infrastructure expands and cardiovascular disease becomes a growing concern across major economies. Increasing investments in cardiac-care facilities, greater awareness of early diagnosis, and expanding access to advanced intervention technologies are expected to support regional adoption.

Looking for more specific insights? Customize this report to suite your business needs

Market Challenges & Dynamics

Despite strong growth prospects, the industry faces challenges associated with stringent regulatory requirements, high technology costs, and the complexity of cardiovascular procedures. Medical-device manufacturers must demonstrate safety and clinical effectiveness before introducing innovative products, while hospitals need highly trained specialists and specialized catheterization infrastructure.

The regulatory environment remains demanding but also supports the introduction of innovative technologies through established approval pathways. Advanced stents, physiology-guided tools, and intravascular imaging systems continue to expand treatment options for complex cardiovascular conditions.

Another important challenge is the cost of advanced intervention technologies. Sophisticated imaging systems, specialized catheters, and next-generation devices can increase procedural expenses, particularly in healthcare systems where access to advanced cardiac technologies remains limited.

Key Market Players & Strategic Developments

The competitive landscape includes major medical-device companies with extensive cardiovascular portfolios. 

Key Interventional Cardiology Devices Companies:

The following key companies have been profiled for this study on the interventional cardiology procedures market.

• Abbott

• Medtronic

• Boston Scientific Corporation

• Cardinal Health

• Koninklijke Philips N.V.

• Terumo Corporation

• Alvimedica

• Teleflex Incorporated

• B. Braun SE

The industry is therefore moving toward a more integrated approach in which devices, imaging, procedural guidance, and digital technologies work together. As cardiovascular disease continues to place pressure on healthcare systems, demand for safer, more precise, and less invasive interventions is expected to remain strong.